These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 9471027

  • 1. Beneficial effect of ursodeoxycholic acid on mucosal damage in trinitrobenzene sulphonic acid-induced colitis.
    Kullmann F, Arndt H, Gross V, Rüschoff J, Schölmerich J.
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1205-11. PubMed ID: 9471027
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Superoxide dismutase ameliorates TNBS-induced colitis by reducing oxidative stress, adhesion molecule expression, and leukocyte recruitment into the inflamed intestine.
    Seguí J, Gironella M, Sans M, Granell S, Gil F, Gimeno M, Coronel P, Piqué JM, Panés J.
    J Leukoc Biol; 2004 Sep; 76(3):537-44. PubMed ID: 15197232
    [Abstract] [Full Text] [Related]

  • 4. 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.
    Santos FA, Silva RM, Campos AR, De Araújo RP, Lima Júnior RC, Rao VS.
    Food Chem Toxicol; 2004 Apr; 42(4):579-84. PubMed ID: 15019181
    [Abstract] [Full Text] [Related]

  • 5. Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis.
    Eliakim R, Karmeli F, Rachmilewitz D, Cohen P, Fich A.
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):1013-9. PubMed ID: 9895047
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
    Takagi T, Naito Y, Okuda T, Uchiyama K, Adachi S, Mizushima K, Handa O, Kokura S, Ichikawa H, Yoshikawa T.
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1259-65. PubMed ID: 20594253
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of berberine chloride on experimental colitis in rats in vivo and in vitro.
    Zhou H, Mineshita S.
    J Pharmacol Exp Ther; 2000 Sep; 294(3):822-9. PubMed ID: 10945829
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effect of epidermal growth factor on experimental colitis in the rat.
    Luck MS, Bass P.
    J Pharmacol Exp Ther; 1993 Feb; 264(2):984-90. PubMed ID: 8382288
    [Abstract] [Full Text] [Related]

  • 13. Alpha-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats.
    Kolgazi M, Jahovic N, Yüksel M, Ercan F, Alican I.
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1859-65. PubMed ID: 17914960
    [Abstract] [Full Text] [Related]

  • 14. Beneficial effect of trimebutine and N-monodesmethyl trimebutine on trinitrobenzene sulfonic acid-induced colitis in rats.
    Chevalier E, Pétoux F, Chovet M, Langlois A.
    Life Sci; 2004 Dec 03; 76(3):319-29. PubMed ID: 15531383
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The effect of angiotensin-converting enzyme inhibitors on experimental colitis in rats.
    Jahovic N, Ercan F, Gedik N, Yüksel M, Sener G, Alican I.
    Regul Pept; 2005 Aug 15; 130(1-2):67-74. PubMed ID: 15908024
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Transforming growth factor-beta gene therapy ameliorates experimental colitis in rats.
    Giladi E, Raz E, Karmeli F, Okon E, Rachmilewitz D.
    Eur J Gastroenterol Hepatol; 1995 Apr 15; 7(4):341-7. PubMed ID: 7600140
    [Abstract] [Full Text] [Related]

  • 19. Ameliorating effects of the immunomodulator 3-(2-ethylphenyl)-5-(3-methoxyphenyl)-1H-1,2,4-triazole in an experimental model of colitis in the rat.
    Stasi MA, Ruggiero V, Ursillo A, Taurelli R, Aglianò M, Weber E, Lorenzoni P, Sorrentino V, Pacifici L, Carminati P.
    Eur J Pharmacol; 2004 Jun 28; 494(2-3):263-72. PubMed ID: 15212983
    [Abstract] [Full Text] [Related]

  • 20. The correlation between NF-κB inhibition and disease activity by coadministration of silibinin and ursodeoxycholic acid in experimental colitis.
    Esmaily H, Vaziri-Bami A, Miroliaee AE, Baeeri M, Abdollahi M.
    Fundam Clin Pharmacol; 2011 Dec 28; 25(6):723-33. PubMed ID: 21077947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.